Terumo Neuro
Lucie Thibault, Pharm.D., possesses extensive experience in the medical device industry, holding multiple leadership roles in clinical marketing, corporate training, and global marketing. At MicroVention-Terumo, Lucie serves as Senior Director of Clinical Marketing and Corporate Training. Previous positions include Director of Global Marketing at Stryker Neurovascular and Director of International Marketing at Boston Scientific, where Lucie also worked as a Territory Sales Manager. Lucie Thibault's educational background includes a Bachelor of Science in Pharmacy and a Doctor of Pharmacy from UCLA and Université de Montréal, respectively.
This person is not in any teams
Terumo Neuro
1 followers
A global leader in neurovascular innovation, MicroVention is now Terumo Neuro. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care. We are in business to create and deliver Game-changing Impact™—innovations that redefine what is possible in neuroendovascular treatment to meaningfully advance both physician practice and patient outcomes. Founded in 1997 as MicroVention and acquired by Terumo Corporation in 2006, Terumo Neuro offers more than thirty products for the treatment of cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. Headquartered in California, Terumo Neuro products are sold in more than seventy countries through a direct sales organization as well as strategic distribution partnerships. Manufacturing facilities are in Aliso Viejo, California, and San José, Costa Rica.